Midazolam increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via the miR-194-5p/HOOK3 axis

BACKGROUNDS: As previously reported, midazolam anesthesia exerts tumor-suppressing effects in non-small cell lung cancer (NSCLC), but the regulating effects of this drug on cisplatin-resistance in NSCLC have not been studied. Thus, we designed this study to investigate this issue and preliminarily d...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Tingting, Chen, Jing, Sun, Xuechao, Wang, Guonian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317376/
https://www.ncbi.nlm.nih.gov/pubmed/34321010
http://dx.doi.org/10.1186/s12935-021-02104-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317376/
https://www.ncbi.nlm.nih.gov/pubmed/34321010
http://dx.doi.org/10.1186/s12935-021-02104-6

Ejemplares similares